The French biotech’s proprietory technology to cultivate pluripotent stem cells in a 3D environment can be scaled to mass-produce high-quality cells to treat diseases such as Parkinson’s
Pluripotent stem cells are master cells that can be used to make different types of cells for various purposes. They can also self-renew and potentially produce any cell or tissue that the body needs to repair itself. In the past, human induced pluripotent stem cell (hiPSC) cultivation took place in the 2D environment of a petri dish, a laborious process that produces poor quality cells in limited quantities – a major barrier to the widespread development of stem cell therapies.French biotech startup TreeFrog Therapeutics has developed a game-changing biocapsule solution to cultivate pluripote...